Pleo Ut S
FDA Label NDC 60681-5403

Full FDA labeling including Indications, Dosage, Usage, and Precautions

Structured Product Label

The following Structured Product Label (SPL) was submitted to the FDA by Sanum Kehlbeck Gmbh & Co. Kg for the product Pleo Ut S (NDC 60681-5403). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.

This specific version of the label includes detailed information regarding indications, ingredients, dosage, warning, tamper evident, principal display panel - 5 capsules carton, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.

Indications

For temporary relief of flu symptoms.

Ingredients

1 capsule contains 330 mg Mycobacterium phlei 6X in a base of lactose.

Dosage

One capsule once weeky, either before breakfast or at bedtime.

Warning

If symptoms persist more than a few days, contact a licensed practitioner. As with any drug, if you are pregnant or nursing a baby, seek the advice of a health care professional before taking this product.

Tamper Evident

Do not use this product if imprinted inner blister pack is broken or if imprinted security strip on carton ist torn.

Principal Display Panel - 5 Capsules Carton

Pleo™ Ut "S"
CAPSULES 6X

Homeopathic
Decongestant / Broncho-
dilator Medicine

Indications: For temporary
relief of flu symptoms.

5 CAPSULES

Principal Display Panel (5 Capsules Carton)

Principal Display Panel (5 Capsules Carton)

* Please review the disclaimer below.